Abstract
Here we report a method for the preparation of anomerically pure β-S-glycopyranosides (1,2-trans-glycosides) from the corresponding peracetate donors. S-glycosylation was performed in CHCl3 at reflux in the presence of a catalytic amount of InBr3. Deacylation of the intermediate peracetates were achieved under Zemplén conditions. Five pyranose examples, monosaccharides D-glucose and D-galactose and disaccharides cellobiose, maltose, and lactose, were used as donors, and five thiols including an α/ω dithiol and Fmoc-L-cysteine were used as acceptors. Melting points, high res MS, [α]D and NMR data (1H and 13C, including COSY, HSQC and HMBC) are reported for compounds not previously described.
Keywords: Thioglycoside, S-glycosidic linkage, Glycolipid, InBr3, Surfactant, Glycosylated cysteine
Glycolipids represent a diverse class of compounds typically found in biological membranes1 and are regarded as environmentally friendly bio-surfactants with broad use in cosmetics, food, environmental and other industrial applications,2 as well as potential therapeutic drug delivery systems.3,4 Despite high surface activity,5 high biodegradability, and low toxicity, their use is still hampered by a lack of knowledge regarding physical properties, including phase behavior. Even less is known about the S-linked thioglycosides. Thioglycosides (S-glycosides)6 may be regarded as relatively inert moieties in vivo,7 or as chemical intermediates that can be oxidatively activated8 to generate glycoside donors.9–11 Thioglycosides were previously prepared from monosaccharide peracetates using a molar excess of BF3•Et2O or SnCl4 as promoters by Kihlberg in the 1990s.12 Here we disclose the catalytic use of a much weaker Lewis acid, InBr3,13 which we dub a “minimally competent” Lewis acid.14 It should be noted that InBr3 and other Lewis acids have been used in conjunction with the O-glycosylation of trichloroacetimidate donors.15 We have previously reported the catalytic use of InBr314 and other Lewis acids16 to generate O-glycosides from weakly electrophilic peracetate sugars.
The surfactant β-S-octyl-glucopyranoside and several of its analogues were previously prepared by S-alkylation of 2-(2,3,4,6-tetra-O-acetyl-β-glucopyranosyl) thiopseudourea•HBr by Saito and Tsuchiya.17 The present approach (Fig. 1) seems to be superior, both in terms of the number of steps and in overall yield. β-D-glucopyranose peracetate 1 was treated with two molar equivalents of 1-octanethiol in CHCl3 at reflux for 1 hour in the presence of 1% InBr3, to form the desired β-peracetate, which was purified by short column chromatography (SiO2). No α anomer was observed. We propose that the formation of the S-glycoside occurs via a similar route to the previously published O-glycoside example, resulting in only the β-S-glycoside.14 The peracetate product was deprotected using Zemplén deacylation18 to provide the desired surfactant.17 The glycosylation produced a similar yield in PhCH3, but the reaction in CH3CN decreased the yield.
Fig. 1.
Preparation of β-thioglycosides.
Several mono- and disaccharide peracetates (1–5) and thiols (6–11, Table 1) were subjected to the reaction conditions to provide a variety of S-glycosides. Bolaamphiphile 15a and mono-glycoside 16a were prepared by adjusting the stoichiometry of the glycosyl donor and acceptor to favor either mono- or di-glycosylation of the α/ω dithiol.
Table 1. Results of InBr3 promoted glycosylations.
Thioglycosides from InBr3 promoted glycosylations of various thiolipids (6–10) and Fmoc-L-cysteine (11) with five peracetylated mono- and disaccharides (1–5) to produce compounds 12–33. After Zemplén deacylation of the lipids, compounds 12a–28a were isolated and characterized. Compounds 12a,19,20 13a,20 14a,20 17a,19,21 18a,22 19a,22 20a,23 22a,24 23a,23 24a,25 25a,24 26a,23 28a,26 29,27 and 3028,29 have been previously reported using alternate reaction conditions. Previously reported deacylated thioglycosides are noted in lit. % indicates combined yields.
Donors | Sulfide acceptors | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R′ |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||||||||||||||||||
R= | Ac | H | Lit | % | Ac | H | Lit | % | Ac | H | Lit | % | Ac | H | Lit | % | Ac | H | Lit | % | Ac | Lit | % | |
![]() |
12 | 12a | 19,20 | 81 | 13 | 13a | 20 | 88 | 14 | 14a | 20 | 84 | 15 | 15a | – | 86 | 16 | 16a | – | 69 | 29 | 27 | 72 | |
![]() |
17 | 17a | 19,21 | 89 | 18 | 18a | 22 | 90 | 19 | 19a | 22 | 92 | 30 | 28,29 | 81 | |||||||||
![]() |
20 | 20a | 23 | 88 | 21 | 21a | – | 66 | 22 | 22a | 24 | 76 | 31 | – | 65 | |||||||||
![]() |
23 | 23a | 23 | 85 | 24 | 24a | 25 | 87 | 25 | 25a | 24 | 88 | 32 | 85 | ||||||||||
![]() |
26 | 26a | 23 | 87 | 27 | 27a | 82 | 28 | 28a | 26 | 80 | 33 | 83 |
Similar reaction conditions were applied to Fmoc-L-cysteine. Glycosylation of neurologically active endogenous peptides has been applied to a number of systems,30 although these modifications have typically been performed by O-glycosylation. O-glycosyl linkages have the drawback of being susceptible to enzymatic degradation and hydrolysis. Therefore, S-glycosylated amino acid building blocks compatible with common solid-phase peptide synthesis conditions are an attractive target. Fmoc-L-Cys(S-D-Gal)-OH has been previously reported by Kamerling et al,29 and Pieters et al,28 although their methodology required the use of excess SnCl4. We report similar yields using catalytic quantities of the minimally competent Lewis acid activator, and show the broad applicability of this approach through conjugation of five mono- and disaccharide glycosyl donors 29–33 to Fmoc-L-cysteine (Fig. 2).
Fig. 2.
Preparation of L-cysteine β-thio-glycosides.
The importance of this study is twofold. First, only catalytic amounts of the Lewis acid promoter are required. Secondly, weakly electrophilic peracetates, generally regarded as synthetic intermediates rather than reactive donors, are suitable. This reduces the number of steps and greatly expands the application of this methodology. We have not observed the corresponding α-thioglycosides in any of the reactions.
1. Experimental section
1.1. Materials and instrumentation
1H and 13C NMR spectra were recorded on a Bruker 400 (400 MHz) spectrometer using CDCl3 and D3COD as solvents with TMS as the internal standard. All NMR spectra were analyzed and interpreted using MestReNova® software. First-order chemical shifts and coupling constants were obtained from 1D spectra; proton and carbon resonances were assigned from COSY, HSQC and HMBC experiments. Mass spectrometry was achieved on a Thermo Finnigan LCQ Deca with positive and negative detection and a 1:1 CH3OH:H2O solvent system. Optical rotation measurements were performed using a JASCO P-1010 polarimeter using the Na D line (589 nm) in MeOH at room temperature, and specific rotation was determined using the JASCO software package. For flash chromatography Silia Flash P60 Silica Gel, 40–63 μm, 60 Å (Silicycle, R1200308) was employed and a Biotage Inc. Horizon HPFC system was utilized.
Preparative HPLC separations were performed on a Gilson HPLC using a Phenomenex C-18 reverse phase column (1000 Å, 50 × 250 mm) with a flow rate of 25 mL/min and detection at 280 nm. Solvent systems A (5% acetonitrile in 0.1% aqueous F3CCOOH) and B (80% acetonitrile in 0.1% aqueous F3CCOOH) were used. A Dikma Technologies Inspire C-18 column (4.6 × 250 mm) and a flow rate of 1.0 mL/min were used for analytical HPLC separations. Thin layer chromatography (TLC) was performed on silica gel 60 F254 (Merck) with detection by UV light and charring with H2SO4. Solvents were dried and distilled according to literature procedures or purchased as anhydrous solvents from a manufacturer. All chemicals were purchased from Aldrich Chemical Company, Acros Chemicals, Chem-Impex International, or EMD Chemicals.
1.2. Alkyl-β−1-thio-D-glycopyranoside (12a–14a, 16a–28a)
Peracetyl-β-D-glycopyranose (1–5, 10 mmol), InBr3 (106 mg, 0.3 mmol, 0.03 eq), and alkane-1-thiol (20 mmol, 2 eq) were suspended in CHCl3 (7 mL). The reaction mixture was heated to reflux with magnetic stirring. The course of the reaction was followed by TLC (hexane:EtOAc 1:1). After 1 hour the peracetate starting material could no longer be detected by TLC. The reaction was cooled to RT, diluted with CH2Cl2 (20 mL), and this solution was applied to a short column (4 cm × 12 cm) of SiO2. The HOAc that was formed from the reaction and the excess alkane-1-thiol were eluted with hexanes. The desired thio-glycoside peracetate was eluted with hexanes:EtOAc 7:3. The fractions containing the desired material were combined, concentrated in vacuo, and the intermediate peracetates (12–14, 16–28) were characterized by 1D, 2D, 1H-NMR and 13CNMR in CDCl3 (in Tables in Supplementary data).
Zemplén’s method was used to deprotect the peracetates.18 The thio-glycopyranoside peracetates were dissolved in anhydrous CH3OH (100 mL) and the basicity was adjusted to pH = 9 by addition NaOCH3. After 16 hours, the deacetylation was deemed complete by TLC. Dowex® resin (H+ form) was added until the pH was slightly acidic, the resin was filtered off, and the solution was concentrated, to provide 12a–14a, 16a–28a, which were characterized.
1.3. 1,10 Dithio-β-D-glucopyranosyl-decane (15a)
Peracetyl-β-D-glucopyranose (25 mmol), InBr3 (3 mmol, 0.03 eq), and decane-1,10-dithiol (10 mmol, 1 eq) were reacted using the previous method to provide 15a. M.p. 124–132 °C (crystallization from MeOH–Et2O), [α]D −36.5° (c 0.13, in MeOH), MS (ESI HRMS) for C22H42O10S2 (+Na) 553.21116, found 553.21195 [M + Na]+.
1.3.1. 1-Thio-β-D-glucopyranosyl-10-thiol-decane (16a)
M.p. 95–97 °C (crystallization from MeOH–Et2O), [α]D −17.8° (c 0.20, in MeOH), MS (ESI HRMS) for C16H32O5S2 (+Na) 391.15834, found 391.15875 [M + Na]+.
1.3.2. Decyl-β-thio-cellobioside (21a)
M.p. 200–214 °C (crystallization from MeOH–Et2O), [α]D −22.1° (c 0.26, in MeOH), MS (ESI HRMS) for : C22H42O10S (+Na) 521.23909, found 521.24009 [M + Na]+.
1.3.3. Decyl-β-thio-lactoside (27a)
M.p. Decomp. ~ 200 °C (crystallization from MeOH–Et2O), [α]D −18.3° (c 0.40, in MeOH), MS (ESI HRMS) for C22H42O10S (+Na) 521.23909, found 521.24000 [M + Na]+.
1.4. Nα-Fluoren-9-ylmethoxycarbonyl-S-(peracetyl-β-D-glyco-pyranosyl)-L-cysteine (29–33)
Peracetyl-β-D-glycopyranose (0.6 mmol, 2eq), InBr3 (21 mg, 0.06 mmol, 0.2 eq), and Nα-fluoren-9-ylmethoxycarbonyl-L-cysteine (11, 103 mg, 0.3 mmol, 1 eq) were suspended in CHCl3 (1.5 mL). The reaction mixture was heated to reflux with magnetic stirring. The course of the reaction was followed by analytical HPLC. After 1 hour HPLC indicated >80% conversion (see Table 1) of Fmoc-Cys(SH)-OH to the desired product. Additional reaction time yielded no further reaction progress that could be detected by HPLC. The reaction mixture was concentrated in vacuo, and the residue was purified by preparative HPLC on a C18 reverse phase column with H2O-CH3CN gradient. The appropriate fractions were freeze-dried and the solid residue was characterized.
1.4.1. Nα-Fluoren-9-ylmethoxycarbonyl-S-(peracetyl-β-D-cellobiosyl)-L-cysteine (31)
Phase transition point 104–105 °C (lyophilization from CH3CN/H2O), [α]D −20.7° (c 0.15, in MeOH), MS (ESI HRMS) for C44H51NO21S (+Na) 984.25665, found 984.25901 [M + Na]+.
1.4.2. Nα-Fluoren-9-ylmethoxycarbonyl-S-(peracetyl-β-D-maltobiosyl)-L-cysteine (32)
Phase transition point 103–104 °C (lyophilization from CH3CN/H2O), [α]D +21.5° (c 0.14, in MeOH), MS (ESI HRMS) for C44H51NO21S (+Na) 984.25665, found 984.25866 [M + Na]+.
1.4.3. Nα-Fluoren-9-ylmethoxycarbonyl-S-(peracetyl-β-D-lactosyl)-L-cysteine (33)
Phase transition point 109–110 °C (lyophilization from CH3CN/H2O), [α]D −20.6 (c 0.17, in MeOH), MS (ESI HRMS) for C44H51NO21S (+Na) 984.25665, found 984.25817 [M + Na]+.
Supplementary Material
Acknowledgements
We acknowledge support of this research through grants from the NSF/EPA Networks for Sustainable Molecular Design and Synthesis (NSMDS) program (CHE-1339597), the Michael J. Fox Foundation, and the Migraine Research Foundation.
Footnotes
Appendix: Supplementary material
Supplementary data to this article can be found online at doi:10.1016/j.carres.2015.12.008.
References
- 1.Brown DA, London E. J Membr Biol 1998;164:103–14. [DOI] [PubMed] [Google Scholar]
- 2.Kitamoto D, Morita T, Fukuoka T, Konishi MA, Imura T. Curr Opin Colloid In 2009;14:315–28. [Google Scholar]
- 3.Salim M, Minamikawa H, Sugimura A, Hashim R. Medchemcomm 2014;5:1602–18. [Google Scholar]
- 4.Rodrigues LR. J Colloid Interface Sci 2015;449:304–16. [DOI] [PubMed] [Google Scholar]
- 5.Niraula BB, Chun TK, Othman H, Misran M. Colloid Surface A 2004;248:157–66. [Google Scholar]
- 6.Fischer E, Delbrück K. Ber Dtsch Chem Ges 1909;42:1476–82. [Google Scholar]
- 7.Macauley MS, Stubbs KA, Vocadlo DJ. J Am Chem Soc 2005;127:17202–3. [DOI] [PubMed] [Google Scholar]
- 8.Veeneman GH, Vanleeuwen SH, Vanboom JH. Tetrahedron Lett 1990;31:1331–4. [Google Scholar]
- 9.Zhu X, Schmidt RR. Angew Chem Int Ed 2009;48:1900–34. [DOI] [PubMed] [Google Scholar]
- 10.Lloyd D, Bennett CS. J Org Chem 2014;79:9826–9. [DOI] [PubMed] [Google Scholar]
- 11.Codée JDC, Litjens R, van den Bos LJ, Overkleeft HS, van der Marel GA. Chem Soc Rev 2005;34:769–82. [DOI] [PubMed] [Google Scholar]
- 12.Salvador LA, Elofsson M, Kihlberg J. Tetrahedron 1995;51:5643–56. [Google Scholar]
- 13.Coss C, Carrocci T, Maier RM, Pemberton JE, Polt R. Helv Chim Acta 2012;95:2652–9. [Google Scholar]
- 14.Lefever ML, Szabo LZ, Anglin B, Ferracane M, Hogan J, Cooney L, et al. Carbohydr Res 2012;351:121–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Mattson AL, Michel AK, Cloninger MJ. Carbohydr Res 2012;347:142–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Keyari CM, Polt R. J Carbohydr Chem 2010;29:181–206. [Google Scholar]
- 17.Saito S, Tsuchiya T. Chem Pharm Bull 1985;33:503–8. [Google Scholar]
- 18.Zemplén G, Kunz A. Ber Dtsch Chem Ges 1924;57:1357–9. [Google Scholar]
- 19.Galema SA, Engberts J, van Doren HA. Carbohydr Res 1997;303:423–34. [Google Scholar]
- 20.Van Doren HA, Van Der Geest R, Kellogg RM, Wynberg H. Carbohydr Res 1989;194:71–8. [Google Scholar]
- 21.Yde M, Debruyne CK. Carbohydr Res 1973;30:205–6. [Google Scholar]
- 22.Dahlhoff WV, Radkowski K, Riehl K, Zugenmaier P. Z Naturforsch B 1995;50:1079–85. [Google Scholar]
- 23.Defaye J, Gadelle A, Pedersen C. Process for preparing alkyl-1-thioglycosides and alkyl-glycosides, anomer mixtures thereof. US Patent 5,118,804, 1991.
- 24.Mousty C, Maurice C, Mousset G, Schöllhorn B, Lefeuvre M, Plusquellec D. J Colloid Interface Sci 1996;184:671–9. [DOI] [PubMed] [Google Scholar]
- 25.Kumpulainen AJ, Persson CM, Eriksson JC. Langmuir 2004;20:10534–41. [DOI] [PubMed] [Google Scholar]
- 26.Mori M, Kasuya MCZ, Mizuno M, Hatanaka K. Int J Carbohydr Chem 2011;8. [Google Scholar]
- 27.Katayama H, Asahina Y, Hojo H. J Pept Sci 2011;17:818–21. [DOI] [PubMed] [Google Scholar]
- 28.Branderhorst HA, Liskamp RAJ, Pieters RJ. Tetrahedron 2007;63:4290–6. [Google Scholar]
- 29.Maljaars CEP, Halkes KM, de Oude WL, van der Poel S, Pijnenburg NJM, Kamerling JP. J Carbohydr Chem 2005;24:353–67. [Google Scholar]
- 30.Jones EM, Polt R. Front Chem (Lausanne, Switz) 2015;3:40. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.